PUXEDDU, ERMANNO
PUXEDDU, ERMANNO
Dipartimento di Medicina Sperimentale
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD
2013-10-01 Ora, J; Calzetta, L; Pezzuto, G; Senis, L; Paone, G; Mari, A; Portalone, S; Rogliani, P; Puxeddu, E; Saltini, C
A potential role of triple therapy for asthma patients
2019-01-01 Cazzola, M; Puxeddu, E; Matera, Mg; Rogliani, P
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD
2018-03-05 Matera, Mg; Calzetta, L; Puxeddu, E; Rogliani, P; Cazzola, M
Acute COPD exacerbation: 3 T MRI evaluation of pulmonary regional perfusion--preliminary experience.
2014-01-01 Sergiacomi, G; Taglieri, A; Chiaravalloti, A; Calabria, E; Arduini, S; Tosti, D; Citraro, D; Pezzuto, G; Puxeddu, E; Simonetti, Gme
Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients
2022-01-01 Ora, J; Coppola, A; Perduno, A; Manzetti, Gm; Puxeddu, E; Rogliani, P
Adherence to COPD treatment: Myth and reality
2017-01-01 Rogliani, P; Ora, J; Puxeddu, E; Matera, M; Cazzola, M
Airflow obstruction: Is it asthma or is it COPD?
2016-01-01 Rogliani, P; Ora, J; Puxeddu, E; Cazzola, M
An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?
2018-01-01 Cazzola, M; Rogliani, P; Puxeddu, E; Ora, J; Matera, Mg
An unusual outbreak of nontuberculous mycobacteria in hospital respiratory wards: Association with nontuberculous mycobacterial colonization of hospital water supply network
2016-01-01 D'Antonio, S; Rogliani, P; Paone, G; Altieri, A; Alma, M; Cazzola, M; Puxeddu, E
Are there pulmonary sequelae in patients recovering from COVID-19?
2020-10-30 Rogliani, P; Calzetta, L; Coppola, A; Puxeddu, E; Sergiacomi, G; D'Amato, D; Orlacchio, A
Biomarkers for possible early detection and progression of idiopathic pulmonary fibrosis
2021-01-01 Cavalli, F; Puxeddu, E; Teodori, E; Sforza, M; de Marco, P; Rogliani, P
CD71- Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease
2019-01-01 Puxeddu, E; Fraboni, D; Cillis, G; Cavalli, F; Buccisano, F; Rogliani, P
Depressive and anxiety symptoms in patients with SARS-CoV2 infection
2021-01-01 Liguori, C; Pierantozzi, M; Spanetta, M; Sarmati, L; Cesta, N; Iannetta, M; Ora, J; Mina, Gg; Puxeddu, E; Balbi, O; Pezzuto, G; Magrini, A; Rogliani, P; Andreoni, M; Mercuri, Nb
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE
2019-11-01 Del Principe, Mi; Venditti, A; Arcese, W; Cantonetti, M; Buccisano, F; Maurillo, L; De Fabritiis, P; Rogliani, P; Zizzari, Ag; Casciani, P; Laureana, R; Meconi, F; Buzzatti, E; Palmieri, R; De Bellis, E; Pane, G; Nassa, D; Fontana, C; Paterno, G; Sarmati, L; Puxeddu, E; Cefalo, M
Does bronchoscopy help the diagnosis in COVID-19 infection?
2020-01-01 Ora, J; Puxeddu, E; Cavalli, F; Giorgino, Fm; Girolami, A; Chiocchi, M; Sergiacomi, G; Federici, M; Rogliani, P
Dual bronchodilation and exacerbations of COPD
2016-09-01 Cazzola, M; Ora, J; Puxeddu, E
Dyspnea perception and neurological symptoms in non-severe COVID-19 patients
2020-10-01 Ora, J; Liguori, C; Puxeddu, E; Coppola, A; Matino, M; Pierantozzi, M; Mercuri, Nb; Rogliani, P
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study
2018-01-01 Rogliani, P; Ora, J; Puxeddu, E; Calzetta, L; Cavalli, F; Matera, Mg; Cazzola, M
Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol.
2013-01-01 Cazzola, M; Segreti, A; Stirpe, E; Puxeddu, E; Ora, J; Rogliani, P; Matera, Mg
Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations
2019-01-01 Rogliani, P; Matera, Mg; Ritondo, Bl; De Guido, I; Puxeddu, E; Cazzola, M; Calzetta, L
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-ott-2013 | A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD | Ora, J; Calzetta, L; Pezzuto, G; Senis, L; Paone, G; Mari, A; Portalone, S; Rogliani, P; Puxeddu, E; Saltini, C | Articolo su rivista | |
| 1-gen-2019 | A potential role of triple therapy for asthma patients | Cazzola, M; Puxeddu, E; Matera, Mg; Rogliani, P | Articolo su rivista | |
| 5-mar-2018 | A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD | Matera, Mg; Calzetta, L; Puxeddu, E; Rogliani, P; Cazzola, M | Articolo su rivista | |
| 1-gen-2014 | Acute COPD exacerbation: 3 T MRI evaluation of pulmonary regional perfusion--preliminary experience. | Sergiacomi, G; Taglieri, A; Chiaravalloti, A; Calabria, E; Arduini, S; Tosti, D; Citraro, D; Pezzuto, G; Puxeddu, E; Simonetti, Gme | Articolo su rivista | |
| 1-gen-2022 | Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients | Ora, J; Coppola, A; Perduno, A; Manzetti, Gm; Puxeddu, E; Rogliani, P | Articolo su rivista | |
| 1-gen-2017 | Adherence to COPD treatment: Myth and reality | Rogliani, P; Ora, J; Puxeddu, E; Matera, M; Cazzola, M | Articolo su rivista | |
| 1-gen-2016 | Airflow obstruction: Is it asthma or is it COPD? | Rogliani, P; Ora, J; Puxeddu, E; Cazzola, M | Articolo su rivista | |
| 1-gen-2018 | An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations? | Cazzola, M; Rogliani, P; Puxeddu, E; Ora, J; Matera, Mg | Articolo su rivista | |
| 1-gen-2016 | An unusual outbreak of nontuberculous mycobacteria in hospital respiratory wards: Association with nontuberculous mycobacterial colonization of hospital water supply network | D'Antonio, S; Rogliani, P; Paone, G; Altieri, A; Alma, M; Cazzola, M; Puxeddu, E | Articolo su rivista | |
| 30-ott-2020 | Are there pulmonary sequelae in patients recovering from COVID-19? | Rogliani, P; Calzetta, L; Coppola, A; Puxeddu, E; Sergiacomi, G; D'Amato, D; Orlacchio, A | Articolo su rivista | |
| 1-gen-2021 | Biomarkers for possible early detection and progression of idiopathic pulmonary fibrosis | Cavalli, F; Puxeddu, E; Teodori, E; Sforza, M; de Marco, P; Rogliani, P | Articolo su rivista | |
| 1-gen-2019 | CD71- Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease | Puxeddu, E; Fraboni, D; Cillis, G; Cavalli, F; Buccisano, F; Rogliani, P | Articolo su rivista | |
| 1-gen-2021 | Depressive and anxiety symptoms in patients with SARS-CoV2 infection | Liguori, C; Pierantozzi, M; Spanetta, M; Sarmati, L; Cesta, N; Iannetta, M; Ora, J; Mina, Gg; Puxeddu, E; Balbi, O; Pezzuto, G; Magrini, A; Rogliani, P; Andreoni, M; Mercuri, Nb | Articolo su rivista | |
| 1-nov-2019 | DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE | Del Principe, Mi; Venditti, A; Arcese, W; Cantonetti, M; Buccisano, F; Maurillo, L; De Fabritiis, P; Rogliani, P; Zizzari, Ag; Casciani, P; Laureana, R; Meconi, F; Buzzatti, E; Palmieri, R; De Bellis, E; Pane, G; Nassa, D; Fontana, C; Paterno, G; Sarmati, L; Puxeddu, E; Cefalo, M | Articolo su rivista | |
| 1-gen-2020 | Does bronchoscopy help the diagnosis in COVID-19 infection? | Ora, J; Puxeddu, E; Cavalli, F; Giorgino, Fm; Girolami, A; Chiocchi, M; Sergiacomi, G; Federici, M; Rogliani, P | Articolo su rivista | |
| 1-set-2016 | Dual bronchodilation and exacerbations of COPD | Cazzola, M; Ora, J; Puxeddu, E | Articolo su rivista | |
| 1-ott-2020 | Dyspnea perception and neurological symptoms in non-severe COVID-19 patients | Ora, J; Liguori, C; Puxeddu, E; Coppola, A; Matino, M; Pierantozzi, M; Mercuri, Nb; Rogliani, P | Articolo su rivista | |
| 1-gen-2018 | Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study | Rogliani, P; Ora, J; Puxeddu, E; Calzetta, L; Cavalli, F; Matera, Mg; Cazzola, M | Articolo su rivista | |
| 1-gen-2013 | Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol. | Cazzola, M; Segreti, A; Stirpe, E; Puxeddu, E; Ora, J; Rogliani, P; Matera, Mg | Articolo su rivista | |
| 1-gen-2019 | Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations | Rogliani, P; Matera, Mg; Ritondo, Bl; De Guido, I; Puxeddu, E; Cazzola, M; Calzetta, L | Articolo su rivista |